CA
NZ
UK
AU
IND
US
…
Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on ACRO Biomedical Co Ltd (ACBM.US) is limited and the company’s core operations, products and financial position are not reliably documented, making independent assessment difficult. Because verifiable details about growth drivers are unavailable, investors seeking biomedical-sector exposure should view the stock as speculative and rely on improved disclosure to assess long-term prospects.
Key investment risks include the OTC Pink listing and sparse disclosure that create high information, liquidity and regulatory-compliance risk.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -0.10M | -0.04M | -15.87M | -15.87M | -7.70M |
| Net income | -0.10M | -0.04M | -15.87M | -15.87M | -7.70M |
| Selling general administrative | - | 0.04M | - | 5.93M | 2.67M |
| Gross profit | - | - | 0.14M | 0.14M | 0.26M |
| Ebit | - | - | -15.87M | -15.87M | -7.69M |
| Ebitda | -0.15M | - | -15.87M | - | -7.69M |
| Depreciation and amortization | 8.79M | - | 15.87M | - | 7.69M |
| Operating income | -0.15M | -0.04M | -15.87M | -15.87M | -7.69M |
| Other operating expenses | 0.15M | - | 16.53M | - | 8.89M |
| Interest expense | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | - | 0.00M | - | 0.00M | 0.00M |
| Net interest income | - | -0.00M | - | -0.00M | -0.00M |
| Non recurring | - | - | - | - | 5.29M |
| Income tax expense | - | - | -15.87M | - | 0.00M |
| Total revenue | - | 0.00M | 0.66M | 0.66M | 1.20M |
| Total operating expenses | 0.15M | 0.04M | 16.01M | 16.53M | 7.95M |
| Cost of revenue | - | - | 0.52M | 0.52M | 0.94M |
| Total other income expense net | 0.05M | - | -0.00M | - | -0.00M |
| Net income from continuing ops | - | -0.04M | - | -15.87M | -7.69M |
| Net income applicable to common shares | - | - | - | -15.87M | -7.70M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 0.01M | 0.03M | 0.69M | 0.69M | 0.76M |
| Other current assets | 0.01M | - | 0.00M | - | 0.00M |
| Total liab | 0.40M | 0.33M | 0.20M | 0.20M | 0.12M |
| Total stockholder equity | -0.39M | -0.29M | 0.49M | 0.49M | 0.64M |
| Other current liab | 0.10M | - | 0.08M | 0.02M | 0.02M |
| Common stock | 0.06M | - | 0.06M | 0.06M | 0.06M |
| Capital stock | - | 0.06M | - | 0.06M | 0.06M |
| Retained earnings | -32.76M | -32.66M | -23.81M | -23.81M | -7.94M |
| Other assets | - | - | - | 0.00M | 0.00M |
| Cash | 0.00M | 0.00M | 0.01M | 0.01M | 0.10M |
| Total current liabilities | 0.40M | 0.33M | 0.20M | 0.20M | 0.09M |
| Current deferred revenue | 0.02M | - | 0.02M | - | 0.02M |
| Net debt | 0.32M | - | 0.02M | - | -0.04M |
| Short term debt | 0.33M | - | 0.03M | - | 0.02M |
| Short long term debt total | 0.33M | - | 0.03M | - | 0.05M |
| Other stockholder equity | 32.31M | - | 16.17M | -8.06M | 8.52M |
| Property plant equipment | - | - | - | 0.03M | 0.05M |
| Total current assets | 0.01M | 0.01M | 0.66M | 0.66M | 0.71M |
| Net tangible assets | - | - | - | 0.49M | 0.64M |
| Net receivables | - | - | 0.64M | 0.64M | 0.60M |
| Inventory | - | - | 0.01M | 0.01M | 0.01M |
| Accounts payable | 0.06M | 0.15M | 0.08M | 0.08M | 0.03M |
| Accumulated other comprehensive income | - | - | -8.06M | - | - |
| Common stock total equity | - | - | - | - | 0.06M |
| Retained earnings total equity | - | - | - | - | -7.94M |
| Non currrent assets other | 0.00M | - | 0.00M | - | 0.00M |
| Non current assets total | 0.03M | 0.03M | 0.03M | 0.03M | 0.05M |
| Capital lease obligations | - | 0.03M | - | 0.03M | 0.05M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Change to liabilities | - | - | - | 0.05M | 0.00M |
| Net borrowings | - | - | - | 0.06M | 0.02M |
| Total cash from financing activities | 0.20M | 0.04M | 0.06M | 0.06M | -0.22M |
| Change to operating activities | - | - | - | -0.00M | -0.00M |
| Net income | -0.10M | -0.04M | -15.87M | -15.87M | -7.70M |
| Change in cash | 0.00M | 0.00M | -0.09M | -0.09M | 0.08M |
| Begin period cash flow | 0.00M | 0.00M | 0.10M | 0.10M | 0.02M |
| End period cash flow | 0.00M | 0.00M | 0.01M | 0.01M | 0.10M |
| Total cash from operating activities | -0.20M | -0.04M | -0.15M | -0.15M | 0.30M |
| Change to inventory | - | - | - | 0.00M | 0.94M |
| Change to account receivables | 0.16M | 0.00M | -0.04M | -0.04M | -0.60M |
| Other cashflows from financing activities | 0.20M | - | 0.06M | - | -0.22M |
| Change to netincome | - | - | - | 15.71M | 7.65M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change receivables | - | - | - | - | -0.60M |
| Cash flows other operating | - | - | - | - | -0.00M |
| Cash and cash equivalents changes | - | - | - | - | 0.08M |
| Change in working capital | -0.04M | 0.00M | 0.01M | 0.01M | 0.34M |
| Stock based compensation | 8.06M | 0.00M | 15.71M | 15.71M | 7.65M |
| Other non cash items | -0.05M | 0.00M | 0.00M | 0.00M | 0.00M |
| Free cash flow | -0.20M | -0.04M | -0.15M | -0.15M | 0.30M |
Sector: Financial Services Industry: Shell Companies
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ACBM ACRO Biomedical Co Ltd |
- -% |
0.03 | - | - | 8.07 | 518.48 | 193.57 | -10.99 |
| CLUS CLUS |
- -% |
200.00 | - | - | 0.09 | 0.92 | 0.72 | -8.97 |
| SGDH Sgd Holdings Ltd |
- -% |
1.00 | - | - | 59741.55 | 0.56 | 2.50 | -162.10 |
| LION Lionsgate Studios Holding Corp. |
-0.40 3.11% |
12.45 | - | 23.31 | 1.13 | 1.35 | 2.37 | 5.55 |
| QKIE QKIE |
-0.46 23.47% |
1.50 | - | - | 470.20 | - | - | - |
Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
| Name | Title | Year Born |
|---|---|---|
| Mr. An-Tao Fong | Managing Director | NA |
| Mr. Pao-Chi Chu | Chairman, CEO, CFO, Pres & Sec. | 1954 |
| Mr. Che-Li Lin | VP of Technical | NA |
| Mr. Cheng-Hsiang Kao | Managing Director | NA |
| Mr. Yun-Yuan Chu | Managing Director | NA |
| Mr. Pao-Chi Chu | CEO, CFO, President, Secretary & Director | 1954 |
| Mr. Jer-Li Lin | Vice President of Technical | NA |
| Ms. Yu-Ting Su | Chairman, CEO, CFO, President & Secretary | 1988 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...